On the 28th of October, Bristol Myers Squibb celebrated the start of the construction of its first European cell therapy facility at the Leiden Bio Science Park in the Netherlands. The site will be BMS’ first cell therapy facility in Europe, and the fifth in the world.
“This site represents an investment in our future as a company, the evolution of our pipeline and therapies, and the next stage of innovative treatments for patients. Leiden reflects how we are truly fulfilling our vision to transform patients’ lives through science”, says Sally Ann McNab, General Manager, VP at BMS Belgium, Luxembourg and the Netherlands.
The celebration event was concluded with Arjen Schippers, Program Head of Europe Cell Therapy Facility, raising the flag on the new site: “Like the first man on the moon, I am really honoured to plant the BMS flag in Europe. Let this be the symbol of our commitment to discover, develop and deliver innovative medicines to help patients prevail over serious diseases.”